Free Trial

VSee Health (VSEE) 10K Form and Latest SEC Filings 2026

VSee Health logo
$0.18 +0.00 (+1.12%)
Closing price 05/14/2026 04:00 PM Eastern
Extended Trading
$0.18 -0.01 (-2.76%)
As of 05/14/2026 07:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Latest VSee Health SEC Filings & Recent Activity

VSee Health (NASDAQ:VSEE) has submitted 168+ documents to the U.S. Securities and Exchange Commission (SEC) since 2022. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. The most recent filing was a Form 424B3 submitted on April 1, 2026.

Form 4
VSEE HEALTH, INC. Reports Ownership Change on Mar. 24, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

10-K
VSee Health Files Annual Report on Mar. 31, 2026

The 10-K contains VSee Health's audited financial statements, revenue, earnings, and risk factors for the prior fiscal year.

View earnings history

VSee Health SEC Filing History

Browse VSee Health's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
04/01/2026 8:16 PM
VSee Health (1864531) Filer
Form POS EX
04/01/2026 8:21 PM
VSee Health (1864531) Filer
Form 424B3
03/31/2026 4:25 PM
VSee Health (1864531) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/24/2026 3:35 PM
Aisiku Imoigele (2026054) Reporting
VSee Health (1864531) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2026 3:36 PM
Leonard Jerry (2026204) Reporting
VSee Health (1864531) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2026 3:30 PM
METZGER SCOTT (1881390) Reporting
VSee Health (1864531) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2026 3:31 PM
O'SULLIVAN COLIN P. (2026568) Reporting
VSee Health (1864531) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2026 5:01 AM
VSee Health (1864531) Filer
Form 424B3
02/25/2026 3:30 PM
VSee Health (1864531) Issuer
WICKERSHAM DAVID L. (2031519) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2026 4:15 PM
Alta Partners LLC (1896206) Filed by
VSee Health (1864531) Subject
Form SCHEDULE 13G/A
02/19/2026 4:15 PM
VSee Health (1864531) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/17/2026 8:42 PM
ARMISTICE CAPITAL, LLC (1601086) Filed by
VSee Health (1864531) Subject
Form SCHEDULE 13G
02/17/2026 4:25 PM
VSee Health (1864531) Filer
Form DEFA14A
02/05/2026 9:15 AM
VSee Health (1864531) Filer
Form DEF 14A
02/03/2026 11:58 AM
Dominion Capital LLC (1532798) Filed by
VSee Health (1864531) Subject
Form SCHEDULE 13G/A
01/26/2026 4:11 PM
VSee Health (1864531) Filer
Form PRE 14A
01/16/2026 4:00 PM
FAIRFAX CYDONII V. (2031393) Reporting
VSee Health (1864531) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2026 4:00 PM
O'SULLIVAN COLIN P. (2026568) Reporting
VSee Health (1864531) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2026 4:00 PM
LOWDERMILK KEVIN (1952688) Reporting
VSee Health (1864531) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2026 4:01 PM
METZGER SCOTT (1881390) Reporting
VSee Health (1864531) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2026 4:01 PM
VSee Health (1864531) Issuer
WICKERSHAM DAVID L. (2031519) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2026 4:11 PM
VSee Health (1864531) Filer
Form 424B3
01/07/2026 11:15 PM
VSee Health (1864531) Filer
Form EFFECT
01/07/2026 3:15 PM
Leonard Jerry (2026204) Reporting
VSee Health (1864531) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2025 3:33 PM
VSee Health (1864531) Filer
Form S-1
Registration statement under Securities Act of 1933  
12/18/2025 5:37 AM
VSee Health (1864531) Filer
Form DEFA14A
12/18/2025 5:31 AM
VSee Health (1864531) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2025 3:31 PM
VSee Health (1864531) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2025 4:30 PM
VSee Health (1864531) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2025 2:17 PM
VSee Health (1864531) Filer
Form 8-K/A
12/04/2025 5:27 PM
DIGITAL HEALTH SPONSOR LLC (1864530) Reporting
Sands Lawrence M. (1506824) Reporting
VSee Health (1864531) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2025 3:46 PM
Sands Lawrence M. (1506824) Filed by
VSee Health (1864531) Subject
Form SCHEDULE 13D/A
11/28/2025 3:18 PM
VSee Health (1864531) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2025 3:40 PM
VSee Health (1864531) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/24/2025 3:10 PM
VSee Health (1864531) Filer
Form DEF 14A
11/20/2025 4:14 PM
VSee Health (1864531) Filer
Form 10-Q/A
11/17/2025 3:31 PM
VSee Health (1864531) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/17/2025 6:50 AM
VSee Health (1864531) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2025 3:45 PM
Alta Partners LLC (1896206) Filed by
VSee Health (1864531) Subject
Form SCHEDULE 13G
10/29/2025 6:01 AM
VSee Health (1864531) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2025 3:16 PM
VSee Health (1864531) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Before you buy SpaceX shares, consider this alternative approach (Ad)

SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceeding $1.75 trillion - potentially the largest IPO in history. But one expert says buying shares directly may not be the smartest move. There is a lesser-known way to tap into this windfall that most investors haven't considered.tc pixel

Discover the overlooked SpaceX IPO strategy before the June listing
10/22/2025 7:01 AM
VSee Health (1864531) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/20/2025 4:26 PM
VSee Health (1864531) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2025 4:22 PM
VSee Health (1864531) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/15/2025 4:30 PM
VSee Health (1864531) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/14/2025 7:10 AM
VSee Health (1864531) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2025 8:34 PM
VSee Health (1864531) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2025 4:26 PM
Dominion Capital LLC (1532798) Filed by
VSee Health (1864531) Subject
Form SCHEDULE 13G
09/26/2025 7:19 PM
VSee Health (1864531) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2025 4:20 PM
VSee Health (1864531) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/29/2025 5:17 AM
VSee Health (1864531) Filer
Form 10-K/A
08/28/2025 4:31 PM
VSee Health (1864531) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
08/28/2025 4:08 PM
VSee Health (1864531) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/22/2025 4:15 PM
VSee Health (1864531) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2025 7:51 PM
VSee Health (1864531) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

VSee Health SEC Filings - Frequently Asked Questions

VSee Health (VSEE) has submitted 168+ filings to the SEC since 2022. You can browse the complete history or filter by form type using the tools above.

VSee Health's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results.

The most recent filing was a Form 424B3 submitted on April 1, 2026. View the full filing using the link above.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NASDAQ:VSEE) was last updated on 5/15/2026 by MarketBeat.com Staff.
From Our Partners